Clinical and hepatic evaluation in adult dengue patients: A prospective two-month cohort study;Avaliação das alterações clínicas e hepáticas em pacientes adultos com dengue: Estudo prospectivo em um período de dois meses

Revista da Sociedade Brasileira de Medicina Tropical

Volumn 45, Issue 6, 2012, Pages 675-681

  Tristão Sá, Ricardo ^a   Kubelka, Claire Fernandes ^b   Zandonade, Eliana ^c   Zagne, Sônia Maria Oliveira ^d   de Souza Maciel Rocha, Natally ^e   Zagne, Luiza Oliveira ^e   Araújo, Nathália Félix ^e   Amin, Beatriz ^e   Fazoli, Flávia ^e   de Souza, Luiz José ^e   Cruz, Oswaldo Gonçalves ^b   da Cunha, Rivaldo Venâncio ^f   do Nascimento, Delso ^f   Froes, Íris Bucher ^f   Nogueira, Rita Maria Ribeiro ^b  

^a Escola Superior de Ciencias da Santa Casa de Misericordia de Vitoria   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

^d FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^e Centro de Referência de Dengue de Campos dos Goytacazes   (Brazil)

^f FEDERAL UNIVERSITY OF MATO GROSSO DO SUL   (Brazil)

Author keywords

Dengue; Hepatic dysfunction; Persistence of symptoms; Prospective cohort

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANOREXIA; ARTHRALGIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ASTHENIA; COHORT ANALYSIS; CONTROLLED STUDY; CONVALESCENCE; DENGUE; DISEASE SEVERITY; DYSGEUSIA; FATIGUE; FEMALE; FOLLOW UP; HAIR LOSS; HUMAN; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; SEX DIFFERENCE; WEAKNESS;

ADULT; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; BILIRUBIN; COHORT STUDIES; CREATINE KINASE; DENGUE; FEMALE; HUMANS; LIVER DISEASES; LIVER FUNCTION TESTS; MALE; PREGNANCY; PROSPECTIVE STUDIES; PROTHROMBIN TIME; SEVERITY OF ILLNESS INDEX;

DENGUE VIRUS; HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 84872302333     PISSN: 00378682     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0037-86822012000600004     Document Type: Article

References (41)

1. World Health Organization Dengue: Guidelines for Diagnosis, Treatment Prevention and Control. Geneva, Switzerland: World Health Organization; 2009.
2. Gubler DJ, Trent DW. Emergence of epidemic dengue/dengue hemorrhagic fever as a public health problem in the Americas. Infect Agents Dis 1993; 2:383-393.
3. San Martin JL, Brathwaite O, Zambrano B, Solorzano JO, Bouckenooghe A, Dayan GH, et al. The epidemiology of dengue in the Americas over the last three decades: a worrisome reality. Am J Trop Med Hyg 2010; 82:128-135.
4. Ribeiro AF, Marques GR, Voltolini JC, Condino ML. Association between dengue incidence and climatic factors. Rev Saude Publica 2006; 40:671-676.
5. Pan American Health Organization. Health Surveillance and Disease Prevention and Control/Communicable Diseases/Dengue 2008: Available from: http://www.paho.org/english/ad/dpc/cd/dengue-cases-2008.htm.
6. World Health Organization. Dengue Hemorrhagic Fever: diagnosis, treatment, prevention and control. 2nd ed. Geneva: World Health Organization; 1997.
7. Halstead SB. Pathogenesis of dengue: challenges to molecular biology. Science 1988; 239:476-481.
8. Uehara PM, Cunha RV, Pereira GROL, Oliveira PA. Envolvimento hepático em pacientes com dengue hemorrágico: manifestação rara? Rev Soc Bras Med Trop 2006; 39:544-547.
9. Souza LJ, Alves JG, Nogueira RM, Gicovate Neto C, Bastos DA, Siqueira EW, et al. Aminotransferase changes and acute hepatitis in patients with dengue fever: analysis of 1, 585 cases. Braz J Infect Dis 2004; 8:156-163.
10. Souza LJ, Carneiro HG, Souto Filho JTD, Souza TF, Cortes VA, Gicovate Neto C, et al. Hepatitis in dengue shock syndrome. Braz J Infect Dis 2002; 6:322-327.
11. Alvarez ME, Ramirez-Ronda CH. Dengue and hepatic failure. Am J Med 1985; 79:670-674.
12. Halstead SB. Dengue. Lancet 2007; 370:1644-1652.
13. Seet RC, Quek AM, Lim EC. Post-infectious fatigue syndrome in dengue infection. J Clin Virol 2007; 38:1-6.
14. Finsterer J, Kongchan K. Severe, persisting, steroid-responsive Dengue myositis. J Clin Virol 2006; 35:426-428.
15. Low JG, Ooi EE, Tolfvenstam T, Leo YS, Hibberd ML, Ng LC, et al. Early Dengue infection and outcome study (EDEN) - study design and preliminary findings. Ann Acad Med Singapore 2006; 35:783-789.
16. Trung DT, Thao le TT, Hien TT, Hung NT, Vinh NN, Hien PT, et al. Liver involvement associated with dengue infection in adults in Vietnam. Am J Trop Med Hyg 2010; 83:774-780.
17. Parkash O, Almas A, Jafri SM, Hamid S, Akhtar J, Alishah H. Severity of acute hepatitis and its outcome in patients with dengue fever in a tertiary care hospital Karachi, Pakistan (South Asia). BMC Gastroenterol 2010; 10:43.
18. Lanciotti RS, Calisher CH, Gubler DJ, Chang GJ, Vorndam AV. Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction. J Clin Microbiol 1992; 30:545-551.
19. Nogueira RM, Schatzmayr HG, Filippis AM, Santos FB, Cunha RV, Coelho JO, et al. Dengue virus type 3, Brazil, 2002. Emerg Infect Dis 2005; 11:1376-1381.
20. Miagostovich MP, Nogueira RM, Santos FB, Schatzmayr HG, Araujo ES, Vorndam V. Evaluation of an IgG enzyme-linked immunosorbent assay for dengue diagnosis. J Clin Virol 1999; 14:183-189.
21. Teixeira LA, Lopes JS, Martins AG, Campos FA, Miranzi SS, Nascentes GA. Persistence of dengue symptoms in patients in Uberaba, Minas Gerais State, Brazil. Cad Saude Publica 2010; 26:624-630.
22. Garcia G, Gonzalez N, Perez AB, Sierra B, Aguirre E, Rizo D, et al. Long-term persistence of clinical symptoms in dengue-infected persons and its association with immunological disorders. Int J Infect Dis 2011; 15:e38-43.
23. Chaturvedi U, Nagar R, Shrivastava R. Dengue and dengue haemorrhagic fever: implications of host genetics. FEMS Immunol Medical Microbiol 2006; 47:155-166.
24. Harrison S, Bergfeld W. Diffuse hair loss: its triggers and management. Cleve Clin J Med 2009; 76:361-367.
25. Lee MS, Hwang KP, Chen TC, Lu PL, Chen TP. Clinical characteristics of dengue and dengue hemorrhagic fever in a medical center of southern Taiwan during the 2002 epidemic. J Microbiol Immunol Infect 2006; 39:121-129.
26. Passos SR, Bedoya SJ, Hokerberg YH, Maia SC, Georg I, Nogueira RM, et al. Clinical and laboratory signs as dengue markers during an outbreak in Rio de Janeiro. Infection 2008; 36:570-574.
27. Kremer AE, Oude-Elferink RP, Beuers U. Pathophysiology and current management of pruritus in liver disease. Clin Res Hepatol Gastroenterol 2011;35:89-97.
28. Burke DS, Nisalak A, Johnson DE, Scott RM. A prospective study of dengue infections in Bangkok. Am J Trop Med Hyg 1988; 38:172-180.
29. Halstead SB, Nimmannitya S, Cohen SN. Observations related to pathogenesis of dengue hemorrhagic fever. IV. Relation of disease severity to antibody response and virus recovered. Yale J Biol Med 1970; 42:311-328.
30. Zagne SM, Alves VG, Nogueira RM, Miagostovich MP, Lampe E, Tavares W. Dengue haemorrhagic fever in the state of Rio de Janeiro, Brazil: a study of 56 confirmed cases. Trans R Soc Trop Med Hyg 1994; 88:677-679.
31. Passos MN, Santos LM, Pereira MR, Casali CG, Fortes BP, Ortiz-Valencia LI, et al. Clinical differences observed in patients with dengue caused by different serotypes in the epidemic of 2001/2002, occurred in Rio de Janeiro. Rev Soc Bras Med Trop 2004; 37:293-295.
32. Thomas L, Verlaeten O, Cabie A, Kaidomar S, Moravie V, Martial J, et al. Influence of the dengue serotype, previous dengue infection, and plasma viral load on clinical presentation and outcome during a dengue-2 and dengue-4 co-epidemic. Am J Trop Med Hyg 2008; 78:990-998.
33. Sierra CB, Kouri G, Guzman MG. Race: a risk factor for dengue hemorrhagic fever. Arch Virol 2007; 152:533-542.
34. Blanton RE, Silva LK, Morato VG, Parrado AR, Dias JP, Melo PR, et al. Genetic ancestry and income are associated with dengue hemorrhagic fever in a highly admixed population. Eur J Hum Genet 2008; 16:762-765.
35. Seneviratne SL, Malavige GN, Silva HJ. Pathogenesis of liver involvement during dengue viral infections. Trans R Soc Trop Med Hyg 2006; 100:608-614.
36. Kuo CH, Tai DI, Chang-Chien CS, Lan CK, Chiou SS, Liaw YF. Liver biochemical tests and dengue fever. Am J Trop Med Hyg 1992; 47:265-270.
37. Miller RRGO. Laboratório para o Clínico. 8th ed. Rio de Janeiro: Editora Atheneu; 1999.
38. Sorbi D, Boynton J, Lindor KD. The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease. Am J Gastroenterol 1999; 94:1018-1022.
39. Ranganathan SS, Sathiadas MG, Sumanasena S, Fernandopulle M, Lamabadusuriya SP, Fernandopulle BM. Fulminant hepatic failure and paracetamol overuse with therapeutic intent in febrile children. Indian J Pediatr 2006; 73:871-875.
40. Srikiatkhachorn A, Green S. Markers of dengue disease severity. Curr Topics Microbiol Immunol 2010; 338:67-82.
41. Clyde K, Kyle JL, Harris E. Recent advances in deciphering viral and host determinants of dengue virus replication and pathogenesis. J Virol 2006; 80:11418-11431.